Cancer Family
Benign Head and Neck Neoplasm
CI-CAN-00000082Explore in graph →
- NCIt
- C173932
Loading cancer entity…
Cancer Family
CI-CAN-00000082Explore in graph →
Variants & evidence
2 evidence items mapped to this entity or its descendants, grouped by molecular profile, then therapy. 50 items per page.
| Therapy | Cancer | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| CTNNB1 I35T + FBXW11 F517SFBXW11CTNNB11 | ||||||||
| (diagnostic) | Basal Cell AdenomaALIAS | Diagnostic | B | Supports Positive | 4 | submitted | EID12637A comprehensive molecular profiling (whole exome and whole transcriptome sequencing) determined that CTNNB1 I35T and FBXW11 F517S missense mutations were mutually exclusive and collectively account fo… (full text at CIViC) PMID 40389436 · Wong et al., 2025 · Open in CIViC | civic |
| NF2 Mutation1 | ||||||||
| Everolimus | Vestibular SchwannomaALIAS | Predictive | B | Supports N/A | 3 | rejected | EID1671Ten patients with Neurofibromatosis 2 were enrolled for treatment with Everolimus. At 12 months, no patients had reduction in tumor volume >20%, however, five patients had stable disease with a reduc… (full text at CIViC) PMID 25567352 · Goutagny et al., 2015 · Open in CIViC | civic |
Data updated 23 hours agoSource updated unknownsource: civic (CC0)
Evidence levels, directions and ratings are those assigned by CIViC curators. "Submitted" items have not completed curation review. This is not treatment guidance.